Monitoring of fibrinolytic treatment with chromogenic substrate assays.
作者信息
Juhan-Vague I, Aillaud M F, Chiche G
出版信息
Acta Chir Scand Suppl. 1982;509:125-8.
PMID:6962615
Abstract
摘要
相似文献
1
Monitoring of fibrinolytic treatment with chromogenic substrate assays.用发色底物分析法监测纤溶治疗。
Acta Chir Scand Suppl. 1982;509:125-8.
2
[Position and developmental trends in fibrinolytic therapy].[纤维蛋白溶解疗法的地位及发展趋势]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):6-17.
3
[Laboratory control of fibrinolytic therapy].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):30-7.
4
[Tissue plasminogen activator: mechanism of action and thrombolytic properties].[组织型纤溶酶原激活剂：作用机制及溶栓特性]
Sangre (Barc). 1984;29(4-C):767-73.
5
An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.外周和冠状动脉血栓形成的局部与全身溶栓治疗评估。
Prog Hemost Thromb. 1984;7:325-56.
6
[New thrombolytic drugs].[新型溶栓药物]
Pol Tyg Lek. 1990;45(6-7):127-30.
7
Urokinase.尿激酶
Neonatal Netw. 1996 Dec;15(8):66-8.
8
Chromogenic substrate assays of components of the fibrinolytic system.纤维蛋白溶解系统成分的显色底物测定。
Acta Chir Scand Suppl. 1982;509:129-32.
9
[Role of single chain pro-UK on the initiation and regulation of fibrinolysis].[单链前尿激酶在纤溶启动及调控中的作用]
Rinsho Byori. 1989 Apr;Spec No 81:107-17.
10
[Thrombolytics and their use].[溶栓剂及其应用]
Rev Prat. 1999 Oct 1;49(15):1654-8.
Zotero 插件